|
Vílchez JA, Pérez-Cuellar M, Marín F, Gallego P, Manzano-Fernández S, Valdés M, Vicente V, Noguera-Velasco JA, Lip GY, Ordóñez-Llanos J, Roldán V. sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation. Eur J Clin Invest. 2015 Sep;45(9):899-905. doi: 10.1111/eci.12482. PubMed PMID: 26081996.
AÑO: 2015; IF: 2.687
|
26081996
|
Roldán V, Cancio S, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. Am J Med. 2015 Nov;128(11):1237-43. doi: 10.1016/j.amjmed.2015.05.036. PubMed PMID: 26087049.
AÑO: 2015; IF: 5.61
|
|
Esteve-Pastor MA, Roldán V, Valdés M, Lip GY, Marín F. The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2016;14(2):177-87. doi: 10.1586/14779072.2016.1116941. Epub 2015 Dec 9. Review. PubMed PMID: 26559964.
AÑO: 2016
|
|
Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, Gulizia M, Halvorsen S, Hindricks G, Kuck KH, Moya A, Potpara T, Roldan V, Tilz R, Lip GY; Document reviewers.. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2015 Aug;17(8):1197-214. doi: 10.1093/europace/euv190. PubMed PMID: 26105732.
AÑO: 2015; IF: 4.021
|
|
Jover E, Marín F, Quintana M, Pérez-Andreu J, Hurtado JA, Rodríguez C, Martínez-González J, González-Conejero R, Valdés M, Hernández-Romero D. CALU polymorphism A29809G affects calumenin availability involving vascular calcification. J Mol Cell Cardiol. 2015 May;82:218-27. doi: 10.1016/j.yjmcc.2015.03.015. PubMed PMID: 25823396.
AÑO: 2015; IF: 4.874
|